The city of Lake City, Florida, currently has 3 active clinical trials seeking participants for Migraine research studies.
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Recruiting
The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.
Gender:
ALL
Ages:
Between 6 years and 17 years
Trial Updated:
01/23/2025
Locations: Multi-Specialty Research Associates, Inc., Lake City, Florida
Conditions: Pediatric Migraine
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Recruiting
A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head. It is often accompanied by feeling or being sick and a sensitivity to bright lights and sound. Migraines are caused by a series of events when the brain gets stimulated or activated, which causes the release of chemicals that cause pain. IPN10200 is a medication that stops the release of these chemical messengers. Participants with episodic migraine (EM) or chronic migraine (CM) will b... Read More
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
12/20/2024
Locations: M3 Wake Research/MSRA, LLC, Lake City, Florida
Conditions: Episodic Migraine, Chronic Migraine
Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine
Recruiting
This study is designed to identify at least one dose of BHV-2100 that is safe and effective in reducing headache pain and other symptoms in the treatment of migraine.
Gender:
ALL
Ages:
Between 18 years and 64 years
Trial Updated:
11/20/2024
Locations: WR-MSRA (Multi-Specialty Research Associates), Lake City, Florida
Conditions: Migraine